| Bioactivity | LtaS-IN-2?(compound 13) is a inhibitor of LTA synthesis, and shows antibacterial activity against S. aureus?and S. epidermidis, with the MIC90 of 0.5 μg/mL and 1 μg/mL, respectively. LtaS-IN-2?is a derivative of LtaS-IN-1 (HY-135813)[1]. |
| Name | LtaS-IN-2 |
| Formula | C24H16F5N3O5S |
| Molar Mass | 553.46 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Douglas EJA, Marshall B, Alghamadi A, et al. Improved Antibacterial Activity of 1,3,4-Oxadiazole-Based Compounds That Restrict Staphylococcus aureus Growth Independent of LtaS Function [published online ahead of print, 2023 Oct 13]. ACS Infect Dis. 2023;10.1021/acsinfecdis.3c00250. |